French blood cancer researchers provided some recommendations around older patient care during COVID-19 in The Lancet Oncology. The guideliines were intended to limiit hospiital admissions and exercise caution when starting or continuing treatment for a population that has greater risk because of cumulative factors such as age and potentially greater immunosuppression.
The Société Francophone d’Onco-Gériatrie (SoFOG) and the French cooperative group for clinical research in geriatric oncology DIALOG (GERICO-UCOG) endorsed the following suggestions:
According to the Center of Disease Control (CDC) in the United States, the following people are at greater risk for getting COVID-19:
about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of HealthTree Foundation (formerly Myeloma Crowd).
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.